Identifying Three Psilocybin Use Patterns by Frequency and Quantity
Bethany A. Gray, Olivia L. Bolts, Deborah J. Fidler, Mark A. Prince
Journal of Studies on Alcohol and Drugs August 23, 2024 DOI: 10.15288/jsad.23-00312 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Observational study Peer reviewed |
|---|---|
| Population | People who use psilocybin in nonclinical settings |
| Topics | Psilocybin |
| Keywords | Hallucinogen Forensic engineering |
| Citations | 1 |
| Key findings | Three profiles of psilocybin use in nonclinical settings were identified, differing in frequency and quantity of use and associated with different demographic characteristics. |
Abstract
Psilocybin use in nonclinical settings is heterogeneous. We identified three profiles that differed on frequency and quantity of use and their associated demographic characteristics. Next steps are to identify factors that affect one's likelihood of experiencing particular use outcomes and to explore use variability.
Comparable studies
Other observational and cohort studies on psilocybin, most cited first.
| Study | Year | Design | Participants |
|---|---|---|---|
| Psilocybin for treatment-resistant depression: fMRI-measured brain mechanisms. Patients with treatment-resistant depression | 2017 | Observational cohort | n = 19 |
| Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels Healthy volunteers | 2019 | Observational cohort | n = 8 |
| Increased spontaneous MEG signal diversity for psychoactive doses of ketamine, LSD and psilocybin Humans | 2017 | Observational study | |
| Classic psychedelic use is associated with reduced psychological distress and suicidality in the United States adult population. USA adult respondents from the National Survey on Drug Use and Health (2008-2012) | 2015 | Observational cohort | n = 190,000 |
| Prediction of Psilocybin Response in Healthy Volunteers Healthy volunteers | 2012 | Observational cohort | n = 409 |